JNJ

Johnson & Johnson In 2013: New Revenue Sources And Old OTC Troubles Winding Down
Seeking Alpha
Wed, 01/16/13 - 07:56 am
JNJ
recalls
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Mon, 01/14/13 - 12:00 pm
JNJ
diabetes
FDA
canagliflozin
1 Great Dividend You Can Buy Right Now
Motley Fool
Sat, 01/12/13 - 11:17 am
JNJ
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Sat, 01/12/13 - 11:05 am
JNJ
canagliflozin
diabetes
type 2 diabetes
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Sat, 01/12/13 - 11:04 am
JNJ
Zytiga
prostate cancer
4 Healthcare Stock Stories for Investor Wellbeing
Wall Street Cheat Street
Sat, 01/12/13 - 10:59 am
JNJ
Telik
AbbVie
Pfizer
J&J Failed to Warn of Vaginal Mesh Risks, Lawyer Says
Bloomberg
Fri, 01/11/13 - 11:40 am
JNJ
vaginal mesh
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Fri, 01/11/13 - 11:38 am
FDA
advisory panels
JNJ
diabetes
canagliflozin
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Motley Fool
Thu, 01/10/13 - 09:49 am
diabetes
FDA
JNJ
advisory panel
canagliflozin
Should Any Big Pharma Buy Bausch & Lomb?
Motley Fool
Thu, 01/10/13 - 09:48 am
M&A
Bausch & Lomb
Pfizer
Sanofi
JNJ
Abbott
Merck
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Vivus
Peregrine Pharmaceuticals
JNJ
Cellceutix
J&J Diabetes Pill May Have Heart Risks, FDA Staff Says
Bloomberg
Tue, 01/8/13 - 09:01 am
FDA
diabetes
JNJ
Invokana
Sanofi Buys Rolaids, Plans Product Relaunch in 2013
Motley Fool
Mon, 01/7/13 - 06:53 pm
Rolaids
Sanofi
M&A
OTC
antacids
JNJ
Big News for These 2 Diabetes Hopefuls
Motley Fool
Mon, 01/7/13 - 06:52 pm
diabetes
empagliflozin
Eli Lilly
Invokana
JNJ
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals
J&J Faces First Vaginal Mesh Implant Trial in New Jersey
Bloomberg
Mon, 01/7/13 - 10:21 am
JNJ
vaginal mesh
Abbott, J&J, Sanofi Said to Show Bausch & Lomb Interest
Bloomberg
Fri, 01/4/13 - 09:53 am
Abbott Labs
JNJ
Sanofi
Bausch & Lomb
M&A
What 2013 Has in Store for Johnson & Johnson
Motley Fool
Wed, 01/2/13 - 11:45 am
JNJ
Top Alzheimer's Missteps of 2012
Motley Fool
Mon, 12/31/12 - 11:14 am
Alzheimer's disease
Medivation
Pfizer
Eli Lilly
JNJ
Merck
J&J Sirturo Wins FDA Approval to Treat Drug-Resistant TB
Bloomberg
Mon, 12/31/12 - 10:32 am
JNJ
Sirturo
FDA
tuberculosis

Pages